<DOC>
	<DOCNO>NCT02821819</DOCNO>
	<brief_summary>The purpose prospective single-center study evaluate laboratory outcome random start ovarian stimulation oocytes donor . The study perform egg-donors type treatment potential implement general infertility population .</brief_summary>
	<brief_title>Random-start Ovarian Stimulation Egg-donors ( ROSE )</brief_title>
	<detailed_description>The study group start ovarian stimulation randomly different moment throughout menstrual cycle . Randomization take place day 2-3 menstrual cycle , accord list random allocation treatment egg-donors assigned random start ovarian stimulation : During follicular phase start day 5,7,9,11 13 menstrual cycle luteal phase start LH peak +3 , +5 , +7 , +9 +11 . Egg-donors receive urinary FSH 150-225 IU/d antagonist protocol cetrorelix acetate 0,25 mg/d start five day ovarian stimulation + GnRH agonist trigger triptorelin 0,2 mg final follicular maturation . Foliculometry transvaginal ultrasound serum analysis ( estradiol , progesterone , LH FSH ) include cycle monitoring .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Cetrorelix</mesh_term>
	<mesh_term>Prolactin Release-Inhibiting Factors</mesh_term>
	<criteria>Premenopausal woman 1835 year old FSH level &lt; 10 mIU/ml AFC &gt; 10 Regular cycle BMI &lt; 28 Signed inform consent PCOS patient Allergy gonadotrophin Concomitant participation trial</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>ovarian stimulation</keyword>
	<keyword>random</keyword>
	<keyword>egg donation</keyword>
	<keyword>antagonist</keyword>
	<keyword>gnrh agonist trigger</keyword>
</DOC>